DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Erkan D, Vega J, Ramon G. et al.
A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome.
Arthritis Rheum 2013;
65: 464-471
We do not assume any responsibility for the contents of the web pages of other providers.